Literature DB >> 1864831

Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.

J Panksepp1, P Lensing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1864831     DOI： 10.1007/bf02284764

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN： 0162-3257


× No keyword cloud information.
  18 in total

1.  Effects of narcotic antagonists on self-injurious behavior: a single case study.

Authors:  G A Bernstein; J R Hughes; J E Mitchell; T Thompson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-11       Impact factor: 8.829

2.  Naltrexone in infantile autism.

Authors:  M Campbell; P Adams; A M Small; L M Tesch; E L Curren
Journal:  Psychopharmacol Bull       Date:  1988

3.  A case report of naltrexone treatment of self-injury and social withdrawal in autism.

Authors:  A S Walters; R P Barrett; C Feinstein; A Mercurio; W T Hole
Journal:  J Autism Dev Disord       Date:  1990-06

4.  Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

Authors:  C Gillberg; L Terenius; G Lönnerholm
Journal:  Arch Gen Psychiatry       Date:  1985-08

5.  Naloxone and self-mutilation.

Authors:  J S Richardson; W A Zaleski
Journal:  Biol Psychiatry       Date:  1983-01       Impact factor: 13.382

6.  Naloxone attenuates self-abusive behavior in developmentally disabled clients.

Authors:  C A Sandman; P C Datta; J Barron; F K Hoehler; C Williams; J M Swanson
Journal:  Appl Res Ment Retard       Date:  1983

7.  Naltrexone in treatment of self injurious behavior: a clinical study.

Authors:  L Szymanski; J Kedesdy; S Sulkes; A Cutler; P Stevens-Our
Journal:  Res Dev Disabil       Date:  1987

8.  Naltrexone in autistic children: an acute open dose range tolerance trial.

Authors:  M Campbell; J E Overall; A M Small; M S Sokol; E K Spencer; P Adams; R L Foltz; K M Monti; R Perry; M Nobler
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-03       Impact factor: 8.829

9.  Failure of naloxone to reduce self-injurious behavior in two developmentally disabled females.

Authors:  B E Beckwith; D I Couk; K Schumacher
Journal:  Appl Res Ment Retard       Date:  1986

10.  Rationale for the administration of opiate antagonists in treating infantile autism.

Authors:  S I Deutsch
Journal:  Am J Ment Defic       Date:  1986-05
View more
  5 in total

1.  Brief report: a double-blind study of naltrexone in infantile autism.

Authors:  M Leboyer; M P Bouvard; J M Launay; F Tabuteau; D Waller; M Dugas; B Kerdelhue; P Lensing; J Panksepp
Journal:  J Autism Dev Disord       Date:  1992-06

Review 2.  Opiate antagonists in children and adolescents.

Authors:  N Chabane; M Leboyer; M C Mouren-Simeoni
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 3.  Stereotypic behavior in nonhuman primates as a model for the human condition.

Authors:  Corrine K Lutz
Journal:  ILAR J       Date:  2014

Review 4.  Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

Authors:  Nermin Eissa; Mohammed Al-Houqani; Adel Sadeq; Shreesh K Ojha; Astrid Sasse; Bassem Sadek
Journal:  Front Neurosci       Date:  2018-05-16       Impact factor: 4.677

5.  Measures of gluten-related reactivity in children with autism spectrum disorders in the absence of overt gastrointestinal symptoms: a pilot study from the United Arab Emirates.

Authors:  Mohamed Abdel-Maksoud; Dina Aly El-Gabry; Tahani Al Kayoumi; Jamila Alketbi; Duaa Mohamednour; Mohamed Elhassan Elamin; Marri Subhash Reddy; Zain Ali Al Yafei; Emmanuel Stip; Karim Abdel Aziz; Danilo Arnone
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.